Magnetic fluid doxorubicin-based for applicationin cancer therapy
Saved in:
| Date: | 2014 |
|---|---|
| Main Author: | N. V. Abramov |
| Format: | Article |
| Language: | English |
| Published: |
2014
|
| Series: | Surface |
| Online Access: | http://jnas.nbuv.gov.ua/article/UJRN-0000516614 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Journal Title: | Library portal of National Academy of Sciences of Ukraine | LibNAS |
Institution
Library portal of National Academy of Sciences of Ukraine | LibNASSimilar Items
Properties of ensembles of nanoparticles of magnetite, which are part of magnetic fluid designed for use in cancer therapy
by: N. V. Abramov, et al.
Published: (2012)
by: N. V. Abramov, et al.
Published: (2012)
Ferrofluids based cisplatin for application in cancer therapy
by: N. V. Abramov
Published: (2013)
by: N. V. Abramov
Published: (2013)
Mechanisms of regulatory policy applicationin agriculture
by: N. Vdovenko
Published: (2015)
by: N. Vdovenko
Published: (2015)
Magnetic liquids based on magnetite and doxorubicin for targeted drug delivery
by: A. L. Petranovska, et al.
Published: (2015)
by: A. L. Petranovska, et al.
Published: (2015)
Magnetic fluids and nanocomposites based on Fe3O4
by: L. S. Semko, et al.
Published: (2011)
by: L. S. Semko, et al.
Published: (2011)
Fractal dimension of the breast cancer cells resistant and sensitive to doxorubicin activity
by: Medviediev, O., et al.
Published: (2016)
by: Medviediev, O., et al.
Published: (2016)
Cytotoxic activity of magnet-quided doxorubicin-based nanocomposites with Saccharomyces cerevisiae cells as an example
by: S. P. Turanska, et al.
Published: (2016)
by: S. P. Turanska, et al.
Published: (2016)
Distribution and accumulation of liposomal form of doxorubicin in breast cancer cells of MCF-7 line
by: Rusetskaya, N.V., et al.
Published: (2011)
by: Rusetskaya, N.V., et al.
Published: (2011)
The lipid content of cisplatin- and doxorubicin-resistant MCF-7 human breast cancer cells
by: Todor, I.N., et al.
Published: (2012)
by: Todor, I.N., et al.
Published: (2012)
Immune checkpoint blockade in breast cancer therapy
by: I. A. Gromakova, et al.
Published: (2020)
by: I. A. Gromakova, et al.
Published: (2020)
Immunological Traits of Cryoablation in Combination Therapy of Cancer
by: A. M. Holtsev, et al.
Published: (2019)
by: A. M. Holtsev, et al.
Published: (2019)
Ribonucleases. possible new approach in cancer therapy
by: Shlyakhovenko, V.O.
Published: (2016)
by: Shlyakhovenko, V.O.
Published: (2016)
Ribonucleases. Possible new approach in cancer therapy
by: V. O. Shlyakhovenko
Published: (2016)
by: V. O. Shlyakhovenko
Published: (2016)
Synthesis and properties of magnetic fluids based on nanosized Fe3O4
by: P. P. Gorbik, et al.
Published: (2011)
by: P. P. Gorbik, et al.
Published: (2011)
Precision therapy to target apoptosis in prostate cancer
by: Kulik, G.
Published: (2014)
by: Kulik, G.
Published: (2014)
Precision therapy to target apoptosis in prostate cancer
by: G. Kulik
Published: (2014)
by: G. Kulik
Published: (2014)
Effect of the C60 fullerene, doxorubicin and their complex on cancer and normal cells of BALB/c mice
by: S. V. Prilutskaja, et al.
Published: (2014)
by: S. V. Prilutskaja, et al.
Published: (2014)
Combinatorial strategies in cancer therapy: potentiating cryoablation
by: Dzh. G. Baust, et al.
Published: (2008)
by: Dzh. G. Baust, et al.
Published: (2008)
Stem cell therapy for hereditary breast cancer
by: Rassi, H.
Published: (2009)
by: Rassi, H.
Published: (2009)
Facility development for a combined cancer therapy
by: Fadeev, A.M., et al.
Published: (2012)
by: Fadeev, A.M., et al.
Published: (2012)
Magnetic theranostics of Lewis lung carcinoma with the complex of gadopentetate dimeglumine and doxorubicin
by: V. E. Orel, et al.
Published: (2016)
by: V. E. Orel, et al.
Published: (2016)
Magnetic characteristics and anticancer activity of a nanocomplex consisting of detonation nanodiamond and doxorubicin
by: V. E. Orel, et al.
Published: (2012)
by: V. E. Orel, et al.
Published: (2012)
Lapatinib-based therapy for women with advanced/metastatic HER2 positive breast cancer
by: J. Zekri, et al.
Published: (2015)
by: J. Zekri, et al.
Published: (2015)
Lapatinib-based therapy for women with advanced/metastatic HER2 positive breast cancer
by: Zekri, J., et al.
Published: (2015)
by: Zekri, J., et al.
Published: (2015)
In search of molecular approaches to improving cancer therapy efficacy
by: E. Cherepenko, et al.
Published: (2014)
by: E. Cherepenko, et al.
Published: (2014)
In search of molecular approaches to improving cancer therapy efficacy
by: Cherepenko, E., et al.
Published: (2014)
by: Cherepenko, E., et al.
Published: (2014)
Multifunctional nanosystems based on two fluorescent dyes, doxorubicin and curcumin
by: M. I. Kaniuk
Published: (2022)
by: M. I. Kaniuk
Published: (2022)
The replicative CMG helicase: the ideal target for cancer therapy
by: W. Henderson, et al.
Published: (2020)
by: W. Henderson, et al.
Published: (2020)
Postmastectomy radiation therapy in locally advanced breast cancer
by: G. Yavas, et al.
Published: (2013)
by: G. Yavas, et al.
Published: (2013)
Magnetically sensitive nanocomposites for targeted antitumor therapy with application of gemcitabine
by: N. M. Korniichuk, et al.
Published: (2020)
by: N. M. Korniichuk, et al.
Published: (2020)
Micellar compositions with doxorubicin and their cytotoxicity
by: L. R. Kunytska, et al.
Published: (2016)
by: L. R. Kunytska, et al.
Published: (2016)
Correlation of iodine symporter expression in highly and low malignant cell lines of human breast cancer differed in their sensitivity to doxorubicin
by: Lukianova, N.Yu., et al.
Published: (2016)
by: Lukianova, N.Yu., et al.
Published: (2016)
Role of hormone therapy in treatment of early breast cancer in premenopausal women
by: M. V. Sadchikova, et al.
Published: (2019)
by: M. V. Sadchikova, et al.
Published: (2019)
Mobile genetic elements and cancer. From mutations to gene therapy
by: Kozeretska, I.A., et al.
Published: (2011)
by: Kozeretska, I.A., et al.
Published: (2011)
Adaptor protein Ruk/CIN85 modulates resistance to doxorubicin of murine 4T1 breast cancer cells
by: I. R. Horak, et al.
Published: (2018)
by: I. R. Horak, et al.
Published: (2018)
Individualization of neoadjuvant therapy in patients with locally-distributed breast cancer
by: Ju. Ju. Belevtsova
Published: (2019)
by: Ju. Ju. Belevtsova
Published: (2019)
Prospects for using the phenomenon of macrophages plasticity to evaluate the efficiency of cancer therapy
by: O. O. Kruts, et al.
Published: (2020)
by: O. O. Kruts, et al.
Published: (2020)
Multicritical behaviour in magnetic fluids
by: Schinagl, F., et al.
Published: (1999)
by: Schinagl, F., et al.
Published: (1999)
On possible role of hydrogen peroxide molecules in ion beam therapy of cancer cells
by: S. N. Volkov
Published: (2021)
by: S. N. Volkov
Published: (2021)
Composite materials based on isocyanurate-containing polyurethane with a prolonged release of doxorubicin
by: S. A. Lukashevych, et al.
Published: (2019)
by: S. A. Lukashevych, et al.
Published: (2019)
Similar Items
-
Properties of ensembles of nanoparticles of magnetite, which are part of magnetic fluid designed for use in cancer therapy
by: N. V. Abramov, et al.
Published: (2012) -
Ferrofluids based cisplatin for application in cancer therapy
by: N. V. Abramov
Published: (2013) -
Mechanisms of regulatory policy applicationin agriculture
by: N. Vdovenko
Published: (2015) -
Magnetic liquids based on magnetite and doxorubicin for targeted drug delivery
by: A. L. Petranovska, et al.
Published: (2015) -
Magnetic fluids and nanocomposites based on Fe3O4
by: L. S. Semko, et al.
Published: (2011)